US Patent 10815311 DLL3 binding proteins and methods of use
Patent 10815311 was granted and assigned to Harpoon Therapeutics on October, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 26 Mar, 2023
Golden AI
Infobox
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
108153110
Date of Patent
October 27, 2020
0Patent Application Number
165830700
Date Filed
September 25, 2019
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Edits on 24 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Feb, 2022
Golden AI
Edits made to:
Infobox (+11 properties)
US Patent 10815311 DLL3 binding proteins and methods of use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10815311
Date of patent
October 27, 2020
Patent application number
16583070
Date Filed
September 25, 2019
Patent citations
Patent primary examiner
Find more entities like US Patent 10815311 DLL3 binding proteins and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
